Areti Health is thrilled to announce closing our first institutional funding round led by Preface Ventures and Almaz Capital. This funding will fuel our mission of harnessing the power of generative AI to revolutionize clinical trial recruitment space.
Our technology engages and educates patients about the clinical trial, pre-qualifies and schedules them for appointment in minutes — all autonomously without human coordinator involvement. It analyzes patient behavior and signals and alerts coordinating and recruiting teams for prompt follow-up whenever relevant. With the help of generative AI our coordinator speaks over 50 languages and improves access for underserved populations, patients with disabilities, and non-native English speakers.
We provide an end-to-end recruitment solution starting with running lead sourcing digital media campaigns, connecting to EMR, and lead databases. Our recruitment technology significantly accelerates study timelines, improves patient diversity and access, frees up research site staff, automates recruitment workflows, and cuts advertising spending. We integrate with all major CTMS systems and we are an official CRIO partner. Our deep integration allows us to perform real-time scheduling and patient record creation with traits, pre-qualification results and conversational logs.
Clinical research teams that use our AI Coordinator experience up to 10x boost in recruitment acceleration, improved site and staff efficiency, lowered advertising spending, higher patient satisfaction and better diversity metrics.
Our mission is to revolutionize clinical trial recruitment by building generative AI-based solutions that outperform humans in routine cases which eat up the majority of human bandwidth today and significantly slow down clinical trials. The AI opportunity is well recognized by the clinical trial industry and we are fortunate to be first to market with the recruitment engine. We now aim at cementing our position as a recruitment market leader by building customizable end-to-end solutions that we strongly believe are the only way to add core customer value.
Sincere gratitude to our amazing investors Farooq Abbasi, Pasha Bogdanov, Felix Shpilman, Seva Fridman, Anna Dvornikova, Ilya Strebulaev, Igor Tikhturov, Oleg Tikhturov, Linda Lee, Diego Sternberg, Andres Lawson and Agustin Di Luciano for their belief in us and our vision!
If you are a research site, a CRO, or a sponsor interested in boosting your recruitment by up to 10x, accelerating and derisking your studies, freeing up coordinator staff, reducing your ad spend, and strengthening operations, please get in touch with us on LinkedIn or drop us a line at contact@aretihealth.com.